Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to -$1.35.

  • Cellebrite DI's EPS (Weighted Average and Diluted) rose 219.42% to $0.09 in Q4 2024 from the same period last year, while for Dec 2024 it was -$0.13, marking a year-over-year increase of 70.20%. This contributed to the annual value of -$1.35 for FY2024, which is 213.95% down from last year.
  • According to the latest figures from FY2024, Cellebrite DI's EPS (Weighted Average and Diluted) is -$1.35, which was down 213.95% from -$0.43 recorded in FY2023.
  • In the past 5 years, Cellebrite DI's EPS (Weighted Average and Diluted) registered a high of $0.59 during FY2022, and its lowest value of -$1.35 during FY2024.
  • In the last 3 years, Cellebrite DI's EPS (Weighted Average and Diluted) had a median value of -$0.43 in 2023 and averaged -$0.40.
  • As far as peak fluctuations go, Cellebrite DI's EPS (Weighted Average and Diluted) surged by 650.00% in 2021, and later crashed by 213.95% in 2024.
  • Cellebrite DI's EPS (Weighted Average and Diluted) (Yearly) stood at -$0.08 in 2020, then skyrocketed by 650.00% to $0.44 in 2021, then spiked by 34.09% to $0.59 in 2022, then plummeted by 172.88% to -$0.43 in 2023, then slumped by 213.95% to -$1.35 in 2024.